Bruker (BRKR) Liabilities and Shareholders Equity (2016 - 2025)
Bruker (BRKR) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $6.2 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 7.49% year-over-year to $6.2 billion, compared with a TTM value of $24.9 billion through Dec 2025, up 11.74%, and an annual FY2025 reading of $6.2 billion, up 7.49% over the prior year.
- Liabilities and Shareholders Equity was $6.2 billion for Q4 2025 at Bruker, down from $6.4 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $6.4 billion in Q3 2025 and bottomed at $3.0 billion in Q1 2021.
- Average Liabilities and Shareholders Equity over 5 years is $4.5 billion, with a median of $3.8 billion recorded in 2023.
- The sharpest move saw Liabilities and Shareholders Equity fell 1.05% in 2022, then soared 60.04% in 2024.
- Year by year, Liabilities and Shareholders Equity stood at $3.6 billion in 2021, then dropped by 1.05% to $3.6 billion in 2022, then increased by 17.67% to $4.2 billion in 2023, then skyrocketed by 36.63% to $5.8 billion in 2024, then grew by 7.49% to $6.2 billion in 2025.
- Business Quant data shows Liabilities and Shareholders Equity for BRKR at $6.2 billion in Q4 2025, $6.4 billion in Q3 2025, and $6.3 billion in Q2 2025.